Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.28 (
chloramphenicol acetyltransferase
)
5,100
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The human
DDX13
gene encodes a putative RNA helicase of the DExH-box family. In an earlier report we showed that the human
DDX13
and RD genes were arranged head-to-head in the class III MHC complex and their ATG start codons were separated by 745 base pairs. We have now analyzed the common 745 bp intergenic region in detail and characterized their promoters. Northern blot analysis revealed that
DDX13
and RD exhibit distinct patterns of steady-state expression among multiple human tissues. The promoter regions for
DDX13
and RD genes were identified by deletion analysis from 740 bp to 176 bp of the intergenic region fused to a
chloramphenicol acetyltransferase
(
CAT
) reporter gene using transient transfection assays. Results indicated that a promoter sequence as small as 176 bp is sufficient for basal expression of both genes in HeLa and HepG2 cells. Functional analysis using a bidirectional reporter system demonstrates that the sequence 262 bp proximal to the
DDX13
gene is sufficient for concurrent expression in both directions. However, the common 740 bp intergenic region showed promoter activity in
DDX13
only, suggesting the presence of a negatively acting region for the RD gene within the region -267 to -744. It appears that RD expression is controlled by a complex system of positively and negatively acting elements present on distant portions of both genes.
...
PMID:Identification and characterization of a bidirectional promoter from the intergenic region between the human DDX13 and RD genes. 1077 46